Trump Signs Executive Order to Regulate Pharmaceutical Advertising
President Trump announced plans to crack down on pharmaceutical advertising, aiming to address concerns over overmedicalization of children and the influence of direct-to-consumer drug ads, which have increased prescriptions and raised health risks. The move seeks to strengthen FDA oversight, especially on social media, to ensure more balanced and responsible drug marketing.

